MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KALA had -$10,846K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$10,846K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-7,564 -20,102
Depreciation and amortization
128 135
Non-cash operating lease cost
96 184
Impairment of right-of-use assets
1,411 -
(gain) loss on fair value remeasurement of contingent consideration
4,833 -174
Amortization of debt discount and other non-cash interest
116 359
Stock-based compensation
2,044 4,550
Prepaid expenses and other current assets
1,457 105
Other long-term assets
-7
Accounts payable
259 30
Accrued expenses and other current liabilities
-984 -1,596
Lease liabilities and other long-term liabilities
-100 -180
Net cash used in operating activities
-10,877 -16,558
Purchases of property and equipment and other assets
-1 16
Net cash used in investing activities
1 -16
Payment of principal and payment fee on debt
0 2,500
Payment of issuance costs from issuance of common stock and series i preferred stock
0 120
Payment of principal on finance lease
30 58
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan
60 13
Net cash (used in) provided by financing activities
30 -2,665
Net (decrease) increase in cash and cash equivalents
-10,846 -19,239
Cash and cash equivalents at beginning of period
51,181 -
Cash and cash equivalents at end of period
21,096 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

KALA BIO, Inc. (KALA)

KALA BIO, Inc. (KALA)